RETATRUTIDE

 A

3 Key Points: Retatrutide Data Show Dramatic Weight Loss, Other Benefits

1. Exceptional Weight Loss

   • Retatrutide has demonstrated some of the largest weight reductions seen with anti-obesity medications, with clinical trial participants losing approximately 20–25% or more of body weight over the study period.

2. Triple-Hormone Mechanism

   • Unlike earlier drugs that target one or two pathways, retatrutide acts on GLP-1, GIP, and glucagon receptors, helping to reduce appetite, improve metabolic function, and increase energy expenditure.

3. Additional Health Benefits

   • Beyond weight loss, studies have shown improvements in blood sugar control, cardiometabolic risk factors, waist circumference, blood pressure, and liver fat, suggesting broader benefits for obesity-related health conditions.

Take-home message: Retatrutide is an investigational "triple agonist" obesity treatment that has produced unprecedented weight loss in trials while also improving several metabolic health markers.